Clinical reference
Anti-infective · Aminoglycoside antibiotic · Neonatology, Pediatrics, Infectious disease
Aminoglycoside for aerobic gram-negative bacilli (e.g. Pseudomonas, Klebsiella, E coli). Usually with a β-lactam. IV 4–5 mg/kg per dose, interval Q24–48 h by PMA and postnatal age; infuse over 30 min. Give separate from penicillin-containing compounds. Monitor serum concentrations when therapy >48 h. No longer available in the US.